Leukocyte‐poor platelet‐rich plasma and leukocyte‐rich platelet‐rich plasma promote myoblast proliferation through the upregulation of cyclin A, cdk1, and cdk2
Journal of Orthopaedic Research · 2024-01 · 42 (1) · 32-42
DOI: 10.1002/jor.25666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 09.08.2023. Verfasst von Li-Siou Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Linkou, Taiwan. Hauptthemen laut MEDLINE: Cyclin A, Myoblasts, Platelet-Rich Plasma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Muscle injuries are common among athletes and often treated with platelet‐rich plasma (PRP). However, whether the leukocyte concentration affects the efficacy of PRP in treating muscle injuries remains unclear. This study investigated the effects of leukocyte‐poor platelet‐rich plasma (LP‐PRP) and leukocyte‐rich platelet‐rich plasma (LR‐PRP) on myoblast proliferation and the molecular mechanisms underlying these effects. Myoblasts were treated with 0.5% LP‐PRP, 0.5% LR‐PRP, 1% LP‐PRP, or 1% LR‐PRP for 24 h. The gene expression of the LP‐PRP‐ and LR‐PRP–treated myoblasts was determined using RNA sequencing analysis. Cell proliferation was evaluated using an bromodeoxyuridine (BrdU) assay, and cell cycle progression was assessed through flow cytometry. The expression of cyclin A, cyclin‐dependent kinase 1 (cdk1), and cdk2 was examined using Western blotting. The expression of myoblast determination protein 1 (MyoD1) was examined through Western blotting and immunofluorescence staining. The LP‐PRP and LR‐PRP both promoted the proliferation of myoblasts and increased differential gene expression of myoblasts. Moreover, the LP‐PRP and LR‐PRP substantially upregulated the expression of cyclin A, cdk1, and cdk2. MyoD1 expression was induced in the LP‐PRP and LR‐PRP–treated myoblasts. Our results corroborate the finding that LP‐PRP and LR‐PRP have similar positive effects on myoblast proliferation and MyoD1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Linkou, Taiwan.
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- School of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
- Center of Comprehensive Sports Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
ORCID-Profile: Li-Ping Lin, Tung-Yang Yu
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Chen, L. S., Chen, C. K., Pang, J. S., Lin, L. P., Yu, T. Y., & Tsai, W. C. (2024). Leukocyte‐poor platelet‐rich plasma and leukocyte‐rich platelet‐rich plasma promote myoblast proliferation through the upregulation of cyclin A, cdk1, and cdk2. Journal of Orthopaedic Research, 42(1), 32-42. https://doi.org/10.1002/jor.25666
Vancouver
Chen LS, Chen CK, Pang JS, Lin LP, Yu TY, Tsai WC. Leukocyte‐poor platelet‐rich plasma and leukocyte‐rich platelet‐rich plasma promote myoblast proliferation through the upregulation of cyclin A, cdk1, and cdk2. Journal of Orthopaedic Research. 2024;42(1):32-42. doi:10.1002/jor.25666
BibTeX
@article{Chen2024,
author = {Chen, Li-Siou and Chen, Chih-Kuang and Pang, Jong-Hwei Su and Lin, Li-Ping and Yu, Tung-Yang and Tsai, Wen-Chung},
title = {Leukocyte‐poor platelet‐rich plasma and leukocyte‐rich platelet‐rich plasma promote myoblast proliferation through the upregulation of cyclin A, cdk1, and cdk2},
journal = {Journal of Orthopaedic Research},
year = {2024},
volume = {42},
number = {1},
pages = {32--42},
doi = {10.1002/jor.25666}
}
EUVIMED